Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. | FEBS Open Bio | 2023 | 36579897 | PubTator, text mining | PubMed |
| Atf7ip and Setdb1 interaction orchestrates the hematopoietic stem and progenitor cell state with diverse lineage differentiation. | Proc Natl Acad Sci U S A | 2023 | 36577070 | PubTator, text mining | PubMed |
| Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis. | Cell Mol Gastroenterol Hepatol | 2023 | 36521660 | PubTator, text mining | PubMed |
| Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine. | Innovation (Camb) | 2023 | 36506806 | PubTator, text mining | PubMed |
| The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors. | J Immunother | 2023 | 36472581 | PubTator, text mining | PubMed |
| Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes. | Clin Transl Oncol | 2023 | 36447119 | PubTator, text mining | PubMed |
| High Tumor Infiltrating Lymphocytes Are Associated with Overall Survival and Good Prognostic Parameters in Endometrial Endometrioid Carcinoma Patients. | Turk Patoloji Derg | 2023 | 36441005 | PubTator, text mining | PubMed |
| A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia. | Cancer Med | 2023 | 36440594 | PubTator, text mining | PubMed |
| HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity. | Expert Rev Anti Infect Ther | 2023 | 36437745 | PubTator, text mining | PubMed |
| Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia. | Leukemia | 2023 | 36435884 | PubTator, text mining | PubMed |
| Using an animal model to predict the effective human dose for oral multiple sclerosis drugs. | Clin Transl Sci | 2023 | 36419359 | PubTator, text mining | PubMed |
| Plasma cell neoplasms and related entities-evolution in diagnosis and classification. | Virchows Arch | 2023 | 36414803 | PubTator, text mining | PubMed |
| Hemophagocytic lymphohistiocytosis secondary to diffuse large B-cell lymphoma presenting with recurrent multi-territory infarcts: A case report. | Radiol Case Rep | 2023 | 36411855 | PubTator, text mining | PubMed |
| RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein. | Virus Genes | 2023 | 36409443 | PubTator, text mining | PubMed |
| Increase of mast cells in COVID-19 pneumonia may contribute to pulmonary fibrosis and thrombosis. | Histopathology | 2023 | 36366933 | PubTator, text mining | PubMed |
| Internal RNA 2'O-methylation in the HIV-1 genome counteracts ISG20 nuclease-mediated antiviral effect. | Nucleic Acids Res | 2023 | 36354007 | PubTator, text mining | PubMed |
| Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection. | J Exp Med | 2023 | 36315049 | PubTator, text mining | PubMed |
| Peripheral T-cell lymphoma of the oral cavity: A case report. | Cancer Rep (Hoboken) | 2023 | 36307110 | PubTator, text mining | PubMed |
| Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management. | Am J Hematol | 2023 | 36226409 | PubTator, text mining | PubMed |
| First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma. | Blood Adv | 2023 | 36095303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=35